Article Information
History
- October 22, 2024.
Article Versions
- Version 1 (April 5, 2024 - 13:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Emma Dann1,2,5,*,
- Erin Teeple3,*,
- Rasa Elmentaite2,
- Kerstin B Meyer1,6,
- Giorgio Gaglia3,
- Frank Nestle4,‡,7,
- Virginia Savova3,‡,
- Emanuele de Rinaldis3,+ and
- Sarah A Teichmann2,4,+
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK
- 2Ensocell Therapeutics, BioData Innovation Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA
- 3Precision Medicine & Computational Biology, Sanofi Research US, Cambridge, MA, 01701, USA
- 4Cambridge Stem Cell Institute/Dept Medicine, Jeffrey Cheah Biomedical Centre, University of Cambridge, Puddi Puddicombe Way, Cambridge CB3 0HE, UK
- 5Current affiliation: Department of Genetics, Stanford University, Stanford, CA 94305, USA
- ↵+Co-Corresponding and senior authors: emanuele.derinaldis{at}sanofi.com, sat1003{at}cam.cam.ac.uk
↵* Authors contributed equally